Defectors from Emmanuel Macron's ruling party announced the creation of a new group in France's lower house of parliament on Tuesday, depriving the president of an outright majority and raising pressure for more left-wing policies.
PARIS - Defectors from Emmanuel Macron’s ruling party announced the creation of a new group in France’s lower house of parliament on Tuesday, depriving the president of an outright majority and raising pressure for more left-wing policies.
Seven lawmakers are splintering from Macron’s La Republique En March party to joint the new “Ecology, Democracy, Solidarity” group, which said it would initially count 17 parliamentarians in its ranks. Macron’s party, formed after the former investment banker won the presidency in May 2017, has suffered a string of defections in recent months by parliamentarians frustrated by his tight grip on decision-making and his pro-business policies.
His reform drive has been stalled by the coronavirus pandemic, just as he was seeking to regain momentum after weeks of pension reform protest and before that anti-government “yellow vest” protests.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Macron, Merkel to announce new 'Franco-German initiative' on MondayFrench President Emmanuel Macron and German Chancellor Angela Merkel will present a new Franco-German initiative later on Monday, Macron's office said in a surprise statement.
Read more »
Macron, Merkel to announce new 'Franco-German initiative' on MondayFrench President Emmanuel Macron and German Chancellor Angela Merkel will present a new Franco-German initiative later on Monday, Macron's office said in a surprise statement.
Read more »
EU Parliament says sensitive data of 1,200 officials left exposed on webInformation about more than a thousand staff and members of the European Parliament has been exposed in what a key lawmaker called a 'major data breach'
Read more »
J.C. Penney store closings coming: Retailer trying to avoid liquidation in Chapter 11 bankruptcyThe company said it plans to 'accelerate' permanent store closings as part of its bankruptcy but declined to provide details on which locations it plans to shutter.
Read more »
The 15 Best Face Exfoliators for Soft, Velvety SkinIn the old days, exfoliating your face was about as delicate a process as resurfacing your floors. But the newest generation of products lets you achieve clear, smooth skin without rubbing it raw
Read more »
Life-Saving Drug More Accessible To Lab Rat Than Majority Of AmericansNEW YORK—Noting that the cost of the pharmaceutical drug places it out of reach for most of the U.S. populace, industry analysts confirmed Friday that the life-saving cancer medication Rizolafan remains far more accessible to a laboratory rat than to the vast majority of Americans. “While this drug has shown considerable efficacy in counteracting tumor growth, U.S. citizens who are currently suffering from advanced pancreatic or colorectal cancer are far less likely to obtain a desperately needed dose than any number of albino rodents locked in cages in a biotech firm’s animal lab,” said Mount Sinai chief of medicine Dr. Martin Aberg, who stated that the average rat infected with the terminal illness could expect to receive as much of the medication as needed, while the thousands of people suffering from the same disease who live in the wealthiest country in the world likely would not. “Whereas most cancer-stricken Americans face insurmountable barriers to receiving this drug, ranging from insufficient insurance coverage to unaffordable out-of-pocket costs, and despite the fact that such a treatment could ease their suffering and significantly extend their lives, it is nevertheless consistently and freely available to hundreds of rats, which do not have to contend with any such obstacles.” Analysts also confirmed that the average rodent was provided with more personalized and attentive care than nearly 98 percent of patients in American hospitals.
Read more »